Service
Advisory Council Member, Center for the Neuroscience of Psychedelics [From 2020]
The Center seeks to understand how psychedelics enhance the brain’s capacity for change, to optimize current treatments and create new treatments for mental illness, and to make the term “treatment resistant” obsolete..
Member of the Board of Directors [From 2019]
The International Consortium for Health Outcomes Measurement (ICHOM) advances patient-centered healthcare by developing and promoting standardized Patient-Centered Outcome Measures, prioritizing the clinical and quality-of-life outcomes that matter most to patients.
Leadership Consortium for Value & Science-Driven Health Care [2011-2016]
The National Academy of Medicine’s Leadership Consortium: Collaboration for a Learning Health System provides a trusted venue for national leaders in health and health care to work cooperatively toward their commitment to effective, innovative care.
Member National Biosurveillance Advisory Subcommittee [2008-2011]
The National Biosurveillance Advisory Subcommittee counsels the federal government on the broad range of issues impacting the development and implementation of a nationwide biosurveillance strategy for human health.
Founder, Former CEO & Chairman, Member of the Board of Directors [From 2000]
We Have One Mission: To End ALS. Founded by the ALS community and fueled by your support, the ALS Therapy Development Institute (ALS TDI) is the world's leading drug discovery lab focused solely on ending ALS.